Mondobiotech


Mondobiotech is a Swiss-based biotechnology company focused on developing human peptides as medicaments for patients affected by rare diseases.

History

Mondobiotech was founded in 2000 by Fabio Cavalli and Dorian Bevec.[1] In March 2012, Pharma Times'in exclusive negotiations with Pierrel Research, the contact research division of the Italian company Pierrel.[2]

Research and development

Mondobiotech creates drugs for rare diseases.

Achievements
  • Winner of the Swiss Life Sciences Prize 2005.
  • Selected Technology Pioneer 2008 by The World Economic Forum.

Notes and references
  1. "Archived copy". Archived from the original on 2012-07-20. Retrieved 2012-02-29.CS1 maint: archived copy as title (link)
  2. Mansell, Peter (6 March 2012). "Pierrel in negotiations for mondoBIOTECH merger". Pharma Times. Retrieved 9 March 2015.
gollark: I don't know exactly. Maybe you didn't plan for the demotion.
gollark: See? Implausible. It was NOT accidental. This was planned.
gollark: It was NOT an accident.
gollark: Via ☭lyric☭bad☭promote☭gollark magic.
gollark: It can even optionally use JIT compilation - a C compiler is bundled with the uncompiled form of your code in a shell script (they can contain arbitrary binary bits, see) which then compiles and runs it on the other end.

See also


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.